Evidence map›Paper›PMID 34737195›Full record

ArticleThorax2022

Aerosol emission from the respiratory tract: an analysis of aerosol generation from oxygen delivery systems.

Fergus W Hamilton, Florence K A Gregson, David T Arnold, Sadiyah Sheikh, Kirsty Ward, Jules Brown, Ed Moran, Carrie White, Anna J Morley, AERATOR Group and 4 more

Open access · hybridAbstract read
In one paragraph

Article in Thorax, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 40 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
40citing papers in PubMed, 2 pooled it
10.3field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

40 citing papers in PubMed, 2 syntheses or guidelines pooled it, 74 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Observational
  5. Article
  6. Review
  7. Article
  8. Article
  9. Observational
  10. Article
  11. Aerosol generation during coughing: an observational study.The Journal of laryngology and otology · 2023
    Observational
  12. Article
  13. Review
  14. Article
  15. Article
  16. Review
  17. Article
  18. Review
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 2 institutions in 1 country.

Fergus W Hamilton *Infection Science, North Bristol NHS Trust, Westbury on Trym, UK fergus.hamilton@bristol.ac.uk.ORCID 0000-0002-9760-4059
Florence K A Gregson *Bristol Aerosol Research Centre, School of Chemistry, University of Bristol, Bristol, UK.
David T ArnoldAcademic Respiratory Unit, North Bristol NHS Trust, Westbury on Trym, UK.ORCID 0000-0003-3158-7740
Sadiyah SheikhBristol Aerosol Research Centre, School of Chemistry, University of Bristol, Bristol, UK.
Kirsty WardPhysiotherapy Department, North Bristol NHS Trust, Westbury on Trym, UK.
Jules BrownAnaesthetics and Intensive Care Department, North Bristol NHS Trust, Westbury on Trym, UK.
Ed MoranInfectious Diseases, North Bristol NHS Trust, Bristol, UK.
Carrie WhiteResearch and Development, North Bristol NHS Trust, Westbury on Trym, UK.
Anna J MorleyAcademic Respiratory Unit, North Bristol NHS Trust, Westbury on Trym, UK.
AERATOR Group
Bryan R BzdekBristol Aerosol Research Centre, School of Chemistry, University of Bristol, Bristol, UK.
Jonathan P ReidBristol Aerosol Research Centre, School of Chemistry, University of Bristol, Bristol, UK.
Nicholas A Maskell *Academic Respiratory Unit, North Bristol NHS Trust, Westbury on Trym, UK.
James William Dodd *MRC Integrative Epidemiology Unit, Bristol, UK.ORCID 0000-0003-4805-5759
North Bristol NHS Trust · GBUniversity of Bristol · GB

Funding

Medical Research Council MR/T005114/1Wellcome Trust
6 · The paper itself

Abstract

introductioncontinuous positive airway pressure (CPAP) and high-flow nasal oxygen (HFNO) provide enhanced oxygen delivery and respiratory support for patients with severe COVID-19. CPAP and HFNO are currently designated as aerosol-generating procedures despite limited high-quality experimental data. We aimed to characterise aerosol emission from HFNO and CPAP and compare with breathing, speaking and coughing. MATERIALS AND

methodsHealthy volunteers were recruited to breathe, speak and cough in ultra-clean, laminar flow theatres followed by using CPAP and HFNO. Aerosol emission was measured using two discrete methodologies, simultaneously. Hospitalised patients with COVID-19 had cough recorded using the same methodology on the infectious diseases ward.

resultsIn healthy volunteers (n=25 subjects; 531 measures), CPAP (with exhalation port filter) produced less aerosol than breathing, speaking and coughing (even with large >50 L/min face mask leaks). Coughing was associated with the highest aerosol emissions of any recorded activity. HFNO was associated with aerosol emission, however, this was from the machine. Generated particles were small (<1 µm), passing from the machine through the patient and to the detector without coalescence with respiratory aerosol, thereby unlikely to carry viral particles. More aerosol was generated in cough from patients with COVID-19 (n=8) than volunteers.

conclusionsIn healthy volunteers, standard non-humidified CPAP is associated with less aerosol emission than breathing, speaking or coughing. Aerosol emission from the respiratory tract does not appear to be increased by HFNO. Although direct comparisons are complex, cough appears to be the main aerosol-generating risk out of all measured activities.

Indexed as

COVID-19AerosolsHumansOxygenRespiratory SystemSARS-CoV-2AerosolsOxygeninfection controlnon invasive ventilationrespiratory infectionviral infection

Identifiers

PMID34737195
PMCPMC8867281
OpenAlexW3210957685

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.